VSI Winter 2018-2019 Newsletter
Bibliography and Sources
Back to Newsletter
Bhatnagar A, Kanwar AJ, Parsad D, De D. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study. J Eur Acad Dermatol Venereol. 2007 Nov;21(10):1381-5. https://www.ncbi.nlm.nih.gov/pubmed/17958845
Bishnoi A, Parsad D. Clinical and Molecular Aspects of Vitiligo Treatments. Int J Mol Sci. 2018 May; 19(5): 1509. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983813/
Cheuk S et al. CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. Immunity. Volume 46, Issue 2, 21 February 2017, pp 287-300. https://www.sciencedirect.com/science/article/pii/S1074761317300316
Frisoli ML, Harris JE. Vitiligo: Mechanistic insights lead to novel treatments. J Allergy Clin Immunol. 2017 Sep;140(3):654-662. https://www.ncbi.nlm.nih.gov/pubmed/28778794
Richmond J, Strassner J, Rashighi M, et al. Resident memory and recirculating memory T cells cooperate to maintain disease in a mouse model of vitiligo. DOI: https://doi.org/10.1016/j.jid.2018.10.032. E-Pub 2018 Nov 10. https://www.jidonline.org/article/S0022-202X(18)32802-1/fulltext?rss=yes
Schenkel J, Masopust D. Tissue-Resident Memory T Cells. Immunity. 2014 Dec 18; 41(6): 886–897.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276131/ |